Status:
COMPLETED
Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms?
Lead Sponsor:
Texas Tech University Health Sciences Center, El Paso
Collaborating Sponsors:
BrainScope Company, Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18-85 years
Brief Summary
Since the neurologic symptoms of some COVID patients ('brain fog') resemble those of patients with concussion, the aim of this study is to identify EEG and cognitive function changes in COVID patients...
Detailed Description
1. Screening and Consent - Patients with a diagnosis of COVID-19 will be asked by the research personnel if they are experiencing symptoms of 'brain fog' (confusion, altered memory, headache, trouble ...
Eligibility Criteria
Inclusion
- Current COVID 19 infection
- Experiencing 'brain fog' symptoms (e.g.confusion, mental slowness, unable to concentrate)
- GCS of 14 or 15
- sufficient mental capacity to provide informed consent
- hemodynamically stable
- able to cooperate with EEG collection and neurometric testing
- admitted to a floor bed rather than ICU
Exclusion
- Head or facial trauma
- Any abnormality that would prevent electrodes from being placed on the head
- Known central nervous system (CNS) disease i.e. MS, Parkinson's disease
- Know seizure disorder
- Known dementia
- Metabolic encephalopathy i.e. uremia, hepatic
- Alcohol intoxication to the point they cannot give consent
- Hypoxia that is not corrected to 92% by nasal cannula, or simple face mask
- Chronic alcohol or drug dependence
- Prior cerebrovascular accident (CVA)
- Prior brain surgery
- Known brain mass
- Receiving sedation medications at time of consent
- End stage renal disease (ESRD) on dialysis
- Acute psychosis
Key Trial Info
Start Date :
April 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2024
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT05303116
Start Date
April 21 2022
End Date
February 20 2024
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center of El Paso
El Paso, Texas, United States, 79905